Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients.
Int J Behav Med., Dec;18(4):325-32 (2011)
Colorectal cancer survivorship: movement matters.
Cancer Prev Res (Phila)., Apr;4(4):502-11 (2011)
Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
Clin Colorectal Cancer., Dec;10(4):298-309 (2011)
Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue.
J Mol Diagn., Feb;9(1):70-9 (2007)
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.
Am. J. Clin. Oncol., Feb;31(1):1-5 (2008)
Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
Pharmacotherapy., Nov;28(11 Pt 2):18S-22S (2008)
Implementation of a comprehensive cancer control program at the worksite: year one summary report.
J. Occup. Environ. Med., May;44(5):398-406 (2002)
Feasibility of assessing quality in medical oncology practices.
Cancer Pract., 9(5):231-5 (2001)
Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.
Clin. Cancer Res., Jan;3(1):25-30 (1997)
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.
Cancer Chemother. Pharmacol., Oct;50(4):257-65 (2002)
Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer.
Prev Med., Nov;37(5):424-31 (2003)
Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
J. Clin. Oncol., Nov;5(11):1783-90 (1987)
Satisfaction among cancer outpatients.
Prog. Clin. Biol. Res., 278:227-32 (1988)
Breast screening practices among primary physicians: reality and potential.
J Am Board Fam Pract., 3(1):26-34 (1990)
Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.
Cancer Chemother. Pharmacol., 29(4):305-8 (1992)
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
J. Clin. Oncol., Aug;13(8):1860-70 (1995)
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Semin. Oncol., Aug;22(4 Suppl 9):18-29 (1995)
NCCN Clinical Practice Guidelines in Oncology: colon cancer.
J Natl Compr Canc Netw., Sep;7(8):778-831 (2009)
NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
J Natl Compr Canc Netw., Sep;7(8):838-81 (2009)
Cancer of unknown primary site.
Semin. Oncol., Apr;37(2):71-9 (2010)